A safe and effective micro-choice based rehabilitation for patients with long COVID: results from a quasi-experimental study

At least 65 million people suffer from long COVID. Treatment guidelines are unclear, especially pertaining to recommendations of increased activity. This longitudinal study evaluated safety, changes in functional level and sick leave following a concentrated rehabilitation program for patients with...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2023-06, Vol.13 (1), p.9423-10, Article 9423
Main Authors: Frisk, Bente, Jürgensen, Marte, Espehaug, Birgitte, Njøten, Kiri Lovise, Søfteland, Eirik, Aarli, Bernt Bøgvald, Kvale, Gerd
Format: Article
Language:English
Subjects:
692/1807/1486
692/699/255
692/700/1719
Adult
Aged
COVID-19 - complications
COVID-19 - rehabilitation
Dyspnea
Fatigue
Humanities and Social Sciences
Humans
Long COVID
Longitudinal Studies
Middle Aged
multidisciplinary
Post-Acute COVID-19 Syndrome - rehabilitation
Quality of Life
Quasi-experimental methods
Rehabilitation
Respiration
Science
Science (multidisciplinary)
Sick leave
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:At least 65 million people suffer from long COVID. Treatment guidelines are unclear, especially pertaining to recommendations of increased activity. This longitudinal study evaluated safety, changes in functional level and sick leave following a concentrated rehabilitation program for patients with long COVID. Seventy-eight patients (19–67 years) participated in a 3-day micro-choice based rehabilitation program with 7-day and 3-month follow-up. Fatigue, functional levels, sick leave, dyspnea and exercise capacity were assessed. No adverse events were reported and 97.4% completed the rehabilitation. Fatigue measured with Chalder Fatigue Questionnaire decreased at 7-days [mean difference (MD = − 4.5, 95% CI − 5.5 to − 3.4) and 3-month (MD = − 5.5, 95% CI − 6.7 to − 4.3). Sick leave rates and dyspnea were reduced (p 
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-35991-y